# Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

> **NCT01937130** · PHASE2 · TERMINATED · sponsor: **Conatus Pharmaceuticals Inc.** · enrollment: 23 (actual)

## Conditions studied

- Acute on Chronic Hepatic Failure
- Acute Liver Failure
- Liver Cirrhosis
- Acute Alcoholic Hepatitis

## Interventions

- **DRUG:** IDN-6556
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01937130
- **Lead sponsor:** Conatus Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-02
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Data needs met
- **Last updated:** 2016-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01937130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01937130, "Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01937130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*